Dr. Kunal Roy is Professor & Ex-Head in the Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India (https://sites.google.com/site/kunalroyindia). He has been a recipient of Commonwealth Academic Staff Fellowship (University of Manchester, 2007) and Marie Curie International Incoming Fellowship (University of Manchester, 2013) and a former visiting scientist of Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milano. Italy. The field of his research interest is Quantitative Structure-Activity Relationship (QSAR) and Molecular Modeling with application in Drug Design, Property Modeling and Predictive Ecotoxicology. Dr. Roy has published more than 450 research articles (ORCID: http://orcid.org/0000-0003-4486-8074) in refereed journals (current SCOPUS h index 57; total citations to date more than 17500). He has also coauthored three QSAR-related books (Academic Press and Springer), edited thirteen QSAR books (Springer, Academic Press, and IGI Global), and published twenty five book chapters. Dr. Roy is the Co-Editor-in-Chief of Molecular Diversity (Springer Nature) and an Associate Editor of Computational and Structural Biotechnology Journal (Elsevier). Dr. Roy serves on the Editorial Boards of several International Journals including (1) European Journal of Medicinal Chemistry (Elsevier); (2) Journal of Molecular Graphics and Modelling (Elsevier); (3) Chemical Biology and Drug Design (Wiley); (4) Expert Opinion on Drug Discovery (Informa). Apart from this, Prof. Roy is a regular reviewer for QSAR papers in different journals. Prof. Roy has been a participant in the EU funded projects nanoBRIDGES and IONTOX apart from several national Government funded projects (UGC, AICTE, CSIR, ICMR, DBT, DAE). Prof. Roy has recently been placed in the list of the World's Top 2% science-wide author database (whole career data) (World rank 52 in the subfield of Medicinal & Biomolecular Chemistry) (Ioannidis, John P.A. (2025), "August 2025 data-update for "Updated science-wide author databases of standardized citation indicators", Elsevier Data Repository, V8, link: http://doi.org/10.17632/btchxktzyw.8).

• Section I: Introduction1. Quantitative structure-activity relationships (QSARs) in medicinal chemistry2. Computer-aided Drug Design – An overview3. Structure-based virtual screening in Drug Discovery4. The impact of Artificial Intelligence methods on drug designSection 2. Methods and Case studies5. Graph Machine Learning in Drug Discovery6. Support Vector Machine in Drug Design7. Understanding protein-ligand interactions using state-of-the-art computer simulation methods8. Structure-based methods in drug design9. Structure-based virtual screening10. Deep learning in drug design11. Computational methods in the analysis of viral-host interactions12. Chemical space and Molecular Descriptors for QSAR studies13. Machine learning methods in drug design14. Deep learning methodologies in drug design15. Molecular dynamics in predicting stability of drug receptor interactionsSection 3. Special topics16. Towards models for bioaccumulation suitable for the pharmaceutical domain17. Machine Learning as a Modeling Approach for the Account of Nonlinear Information in MIA-QSAR Applications: A Case Study with SVM Applied to Antimalarial (Aza)aurones18. Deep Learning using molecular image of chemical structure19. Recent Advances in Deep Learning Enabled Approaches for Identification of Molecules of Therapeutics Relevance20. Computational toxicology of pharmaceuticals21. Ecotoxicological QSAR modelling of pharmaceuticals22. Computational modelling of drugs for neglected diseases23. Modelling ADMET properties based on Biomimetic Chromatographic Data24. A systematic chemoinformatic analysis of chemical space, scaffolds and antimicrobial activity of LpxC inhibitorsSection 4. Tools and databases25. Tools and Software for Computer Aided Drug Design and Discovery26. Machine learning resources for drug design27. Building Bioinformatics Web Applications with Streamlit28. Free tools and databases in ligand and structure-based drug design

Dr. Kunal Roy is Professor & Ex-Head in the Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India (https://sites.google.com/site/kunalroyindia). He has been a recipient of Commonwealth Academic Staff Fellowship (University of Manchester, 2007) and Marie Curie International Incoming Fellowship (University of Manchester, 2013) and a former visiting scientist of Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milano. Italy. The field of his research interest is Quantitative Structure-Activity Relationship (QSAR) and Molecular Modeling with application in Drug Design, Property Modeling and Predictive Ecotoxicology. Dr. Roy has published more than 450 research articles (ORCID: http://orcid.org/0000-0003-4486-8074) in refereed journals (current SCOPUS h index 57; total citations to date more than 17500). He has also coauthored three QSAR-related books (Academic Press and Springer), edited thirteen QSAR books (Springer, Academic Press, and IGI Global), and published twenty five book chapters. Dr. Roy is the Co-Editor-in-Chief of Molecular Diversity (Springer Nature) and an Associate Editor of Computational and Structural Biotechnology Journal (Elsevier). Dr. Roy serves on the Editorial Boards of several International Journals including (1) European Journal of Medicinal Chemistry (Elsevier); (2) Journal of Molecular Graphics and Modelling (Elsevier); (3) Chemical Biology and Drug Design (Wiley); (4) Expert Opinion on Drug Discovery (Informa). Apart from this, Prof. Roy is a regular reviewer for QSAR papers in different journals. Prof. Roy has been a participant in the EU funded projects nanoBRIDGES and IONTOX apart from several national Government funded projects (UGC, AICTE, CSIR, ICMR, DBT, DAE). Prof. Roy has recently been placed in the list of the World's Top 2% science-wide author database (whole career data) (World rank 52 in the subfield of Medicinal & Biomolecular Chemistry) (Ioannidis, John P.A. (2025), "August 2025 data-update for "Updated science-wide author databases of standardized citation indicators", Elsevier Data Repository, V8, link: http://doi.org/10.17632/btchxktzyw.8).

• Section I: Introduction1. Quantitative structure-activity relationships (QSARs) in medicinal chemistry2. Computer-aided Drug Design – An overview3. Structure-based virtual screening in Drug Discovery4. The impact of Artificial Intelligence methods on drug designSection 2. Methods and Case studies5. Graph Machine Learning in Drug Discovery6. Support Vector Machine in Drug Design7. Understanding protein-ligand interactions using state-of-the-art computer simulation methods8. Structure-based methods in drug design9. Structure-based virtual screening10. Deep learning in drug design11. Computational methods in the analysis of viral-host interactions12. Chemical space and Molecular Descriptors for QSAR studies13. Machine learning methods in drug design14. Deep learning methodologies in drug design15. Molecular dynamics in predicting stability of drug receptor interactionsSection 3. Special topics16. Towards models for bioaccumulation suitable for the pharmaceutical domain17. Machine Learning as a Modeling Approach for the Account of Nonlinear Information in MIA-QSAR Applications: A Case Study with SVM Applied to Antimalarial (Aza)aurones18. Deep Learning using molecular image of chemical structure19. Recent Advances in Deep Learning Enabled Approaches for Identification of Molecules of Therapeutics Relevance20. Computational toxicology of pharmaceuticals21. Ecotoxicological QSAR modelling of pharmaceuticals22. Computational modelling of drugs for neglected diseases23. Modelling ADMET properties based on Biomimetic Chromatographic Data24. A systematic chemoinformatic analysis of chemical space, scaffolds and antimicrobial activity of LpxC inhibitorsSection 4. Tools and databases25. Tools and Software for Computer Aided Drug Design and Discovery26. Machine learning resources for drug design27. Building Bioinformatics Web Applications with Streamlit28. Free tools and databases in ligand and structure-based drug design

Dr. Kunal Roy is Professor & Ex-Head in the Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India (https://sites.google.com/site/kunalroyindia). He has been a recipient of Commonwealth Academic Staff Fellowship (University of Manchester, 2007) and Marie Curie International Incoming Fellowship (University of Manchester, 2013) and a former visiting scientist of Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milano. Italy. The field of his research interest is Quantitative Structure-Activity Relationship (QSAR) and Molecular Modeling with application in Drug Design, Property Modeling and Predictive Ecotoxicology. Dr. Roy has published more than 450 research articles (ORCID: http://orcid.org/0000-0003-4486-8074) in refereed journals (current SCOPUS h index 57; total citations to date more than 17500). He has also coauthored three QSAR-related books (Academic Press and Springer), edited thirteen QSAR books (Springer, Academic Press, and IGI Global), and published twenty five book chapters. Dr. Roy is the Co-Editor-in-Chief of Molecular Diversity (Springer Nature) and an Associate Editor of Computational and Structural Biotechnology Journal (Elsevier). Dr. Roy serves on the Editorial Boards of several International Journals including (1) European Journal of Medicinal Chemistry (Elsevier); (2) Journal of Molecular Graphics and Modelling (Elsevier); (3) Chemical Biology and Drug Design (Wiley); (4) Expert Opinion on Drug Discovery (Informa). Apart from this, Prof. Roy is a regular reviewer for QSAR papers in different journals. Prof. Roy has been a participant in the EU funded projects nanoBRIDGES and IONTOX apart from several national Government funded projects (UGC, AICTE, CSIR, ICMR, DBT, DAE). Prof. Roy has recently been placed in the list of the World's Top 2% science-wide author database (whole career data) (World rank 52 in the subfield of Medicinal & Biomolecular Chemistry) (Ioannidis, John P.A. (2025), "August 2025 data-update for "Updated science-wide author databases of standardized citation indicators", Elsevier Data Repository, V8, link: http://doi.org/10.17632/btchxktzyw.8).

• Section I: Introduction1. Quantitative structure-activity relationships (QSARs) in medicinal chemistry2. Computer-aided Drug Design – An overview3. Structure-based virtual screening in Drug Discovery4. The impact of Artificial Intelligence methods on drug designSection 2. Methods and Case studies5. Graph Machine Learning in Drug Discovery6. Support Vector Machine in Drug Design7. Understanding protein-ligand interactions using state-of-the-art computer simulation methods8. Structure-based methods in drug design9. Structure-based virtual screening10. Deep learning in drug design11. Computational methods in the analysis of viral-host interactions12. Chemical space and Molecular Descriptors for QSAR studies13. Machine learning methods in drug design14. Deep learning methodologies in drug design15. Molecular dynamics in predicting stability of drug receptor interactionsSection 3. Special topics16. Towards models for bioaccumulation suitable for the pharmaceutical domain17. Machine Learning as a Modeling Approach for the Account of Nonlinear Information in MIA-QSAR Applications: A Case Study with SVM Applied to Antimalarial (Aza)aurones18. Deep Learning using molecular image of chemical structure19. Recent Advances in Deep Learning Enabled Approaches for Identification of Molecules of Therapeutics Relevance20. Computational toxicology of pharmaceuticals21. Ecotoxicological QSAR modelling of pharmaceuticals22. Computational modelling of drugs for neglected diseases23. Modelling ADMET properties based on Biomimetic Chromatographic Data24. A systematic chemoinformatic analysis of chemical space, scaffolds and antimicrobial activity of LpxC inhibitorsSection 4. Tools and databases25. Tools and Software for Computer Aided Drug Design and Discovery26. Machine learning resources for drug design27. Building Bioinformatics Web Applications with Streamlit28. Free tools and databases in ligand and structure-based drug design